FDA clears AmpliVue HSV test

Quidel's (QDEL) AmpliVue HSV 1+2 Assay gets 510(k) approval for the differentiation and detection of herpes simplex viruses 1 and 2.

The product utilizes Helicase Dependent Amplification technology. Previous FDA-approved offerings detect Clostridium difficile and Group B Strep.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs